In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

President Donald Trump signed a new executive order Monday aimed at slashing the cost of prescription drugs in the United ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that consumer prices can be lowered without sacrificing profit margin. Fortunately ...

Drug discovery and development is an extremely lengthy and expensive process; yet drug safety, a fundamental part of this process, continues to be a major unaddressed problem. The problem of ...

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...